U.S. Senator Debbie Stabenow reached out to the FDA regarding Essure when her constituant, Valerie, contacted her.
Below is the email Valerie received from the senator, and also the response the Senator received from the FDA! Please Read the FDA Essure Response!
Thank you for contacting me with concerns about the Federal Drug Administration's Premarket Approval for Essure coils. I am sorry to hear about the health problems you have experienced.
I recently contacted the Federal Drug Administration to convey your concerns about Essure and ask about the timeline for a decision based on the testimony at the hearing held on September 24, 2015. I have enclosed a copy of their response.
As you know, the E-Free Act (HR 3920) was introduced in the U.S. House of Representatives by Representative Mike Fitzpatrick and is presently in the House Committee on Energy and Commerce. You may contact your Congressional Representative to express your support for this bill. You can find your representative at http://www.house.gov/representatives/find. If legislation addressing this issue comes before me in the Senate, I will keep your strong concerns in mind.
Thank you again for contacting me. Please continue to keep me informed about issues of concern to you and your family.